LIFNano Therapeutics company
LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF).
Technology:
P4 Medicine
Industry:
Preventive Medicine
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2015
Employees Number:
1-10
Funding Status:
N/A
Investors Number:
2
Total Funding:
£1M
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Register and Claim Ownership